Sherbrooke Park Advisers LLC Annexon, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 43,031 shares of ANNX stock, worth $227,203. This represents 0.06% of its overall portfolio holdings.
Number of Shares
43,031
Previous 61,109
29.58%
Holding current value
$227,203
Previous $299 Million
14.92%
% of portfolio
0.06%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ANNX
# of Institutions
146Shares Held
102MCall Options Held
178KPut Options Held
159K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$44.6 Million8.98% of portfolio
-
Satter Management Co., L.P.7.41MShares$39.1 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$37 Million1.32% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$34.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$33.9 Million2.49% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $251M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...